Growth pattern and final height after cessation of gonadotropin-suppressive therapy in girls with central sexual precocity

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 9, 2007, Pages 3483-3489

  Lazar, Liora ^a,c   Padoa, Anna ^b   Phillip, Moshe ^a  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b ASSAF HAROFEH MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ESTROGEN; FOLLITROPIN; GONADOTROPIN; LUTEINIZING HORMONE; TRIPTORELIN;

AGE DISTRIBUTION; ANDROGEN BLOOD LEVEL; ARTICLE; BODY HEIGHT; BODY MASS; BONE AGE; CHILD; CONTROLLED STUDY; DRUG WITHDRAWAL; EPIPHYSEAL CARTILAGE; ESTROGEN BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; GROWTH CURVE; GROWTH RATE; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MENARCHE; OUTCOME ASSESSMENT; PRECOCIOUS PUBERTY; PRIORITY JOURNAL; PUBERTY; STATISTICAL SIGNIFICANCE; TREATMENT RESPONSE;

EID: 34548776060     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-0321     Document Type: Article

References (34)

1. Grumbach MM, Styne DM 1998 Puberty: ontogeneity, neuroendocrinology, physiology and disorders. In: Wilson JD, Foster DW, Kronenberg HM, Larsen PR, eds. Williams textbook of endocrinology. 9th ed. Philadelphia: W. B. Saunders Co.; 1509-1625
2. Wheeler MD 1991 Physical changes of puberty. Endocrinol Metab Clin North Am 29:1-14
3. Shankar R, Pescovitz OH 1995 Precocious puberty. Adv Endocrinol Metab 6:55-89
4. Kaplowitz PB, Oberfield SE, and the Drug and Therapeutics and Executive Committees of the Lawson Wilkins Pediatric Endocrine Society 1999 Reexamination of the age limit for defining when puberty is precocious in girls in the United States: implications for evaluation and treatment. Pediatrics 104:936-941
5. Kletter GB, Kelch RP 1994 Clinical review 60: effects of gonadotrophinreleasing hormone analog therapy on adult stature in precocious puberty. J Clin Endocrinol Metab 79:331-334
6. Klein KO, Barnes KM, Jones JV, Feuillan PP, Cutler Jr GB 2001 Increased final height in precocious puberty after long-term treatment with LHRH agonists: the National Institutes of Health experience. J Clin Endocrinol Metab 86:4711-4716
7. Kauli R, Galatzer A, Kornreich L, Lazar L, Pertzelan A, Laron Z 1997 Final height of girls with central precocious puberty untreated versus treated with cyproterone acetate or GnRH analogue. Horm Res 47 54-61
8. Paul DL, Conte FA, Grumbach MM, Kaplan SL 1995 Long-term effect of gonadotropin-releasing hormone agonist therapy on final height and near final height in 26 children with true precocious puberty treated at a median age of less than 5 years. J Clin Endocrinol Metab 80:546-551
9. Oostdijk W, Rikken B, Schreuder S, Otten B, Odink R, Rouwé C Jansen M, Gerver WJ, Waelkens J, Drop S 1996 Final height in central precocious puberty after long term treatment with a slow-release GnRH agonist. Arch Dis Child 75:292-297
10. Carel JC, Roger M, Ispas S, Tondu F, Lahlou N, Blumberg J, Chaussain JL, and the French Study Group of Decapeptyl in Precocious Puberty1999 Final height after long term treatment with triptorelin slow release for central precocious puberty: importance of statural growth after interruption of treatment. J Clin Endocrinol Metab 84:1973-1978
11. Cassio A, Cacciari E, Balsamo A, Bal M, Tassinari D 1999 Randomized trial ofLHRHanalogue treatment on final height in girls with onset of puberty aged 7.5- 8.5 years. Arch Dis Child 81:329-332
12. Bouvattier C, Coste J, Rodrigue D, Teinturier C, Carel JC, Chaussain JL, Bougneres PF 1999 Lack of effect of GnRH agonist on final height in girls with advanced puberty: a randomized long term pilot study. J Clin Endocrinol Metab 84:3575-3578
13. Bailey N, Pinneau SR 1952 Tables for predicting adult height from skeletal age: revised for use with Greulich and Pyle hand standards. J Pediatr 50:432-441
14. Lazar L, Kauli R, Pertzelan A, Phillip M 2002 Gonadotropin- suppressive therapy in girls with early and fast puberty affects the pace of puberty but not total pubertal growth or final height. J Clin Endocrinol Metab. 87 2090-2094
15. Marshall WA, Tanner JM 1969 Variations in the pattern of pubertal changes in girls. Arch Dis Child 44 291-303
16. Briges NA, Cooke A, Healy MJ, Hindmarsh P, Brook CGD 1993 Standards for ovarian volumes in childhood and puberty. Fertil Steril 60:456-460
17. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, Flegal KM, Guo SS, Wei R 2000 CDC growth charts: United States. Adv Data 314:1-27
18. Greulich WW, Pyle SI 1959 Radiographic atlas of skeletal development of the hand and wrist. 2nd ed. Stanford, CA: Stanford University Press
19. Tanner JM, Goldstein H, Whitehouse RH 1970 Standards for children's height at age 2-9 years allowing for height of parents. Arch Dis Child 45:755-762
20. Kauli R, Kornreich L, Laron Z 1990 Pubertal development, growth and final height in girls with sexual precocity after therapy with GnRH-analogue D-TRP-6-LHRH. Horm Res 33:11-17
21. Dixon WJ, ed 1993 BMDP statistical software. Los Angeles: University of California Press
22. Cutler Jr GB 1997 The role of estrogen in bone growth and maturation during childhood and adolescence. J Steroid Biochem Mol Biol 61:141-144
23. Wierman ME, Beardsworth DE, Crawford JD, Crigler Jr JF, Mansfield MJ, Bode HH, Boepple PA, Kushner DC, Crowley Jr WF 1986 Adrenarche and skeletal maturation during luteinizing hormone releasing hormone analogue suppression of gonadarche. J Clin Invest 77: 121-126
24. Palmert MR, Hayden DL, Mansfield MJ, Crigler Jr JF, Crowley Jr WF, Chandler DW, Boepple PA 2001 The longitudinal study of adrenal maturation during gonadal suppression: evidence that adrenarche is a gradual process. J Clin Endocrinol Metab 86:4536-4542
25. Russell DL, Keil MF, Bonat SH, Uwaifo GI, Nicholson JC, McDuffie JR, Hill SC, Yanovski JA 2001 The relation between skeletal maturation and adiposity in African American and Caucasian children. J Pediatr 139:844-848
26. Klein KO, Larmore KA, de Lancey E, Brown JM, Considine RV, Hassink SG 1998 Effect of obesity on estradiol level, and its relationship to leptin, bone maturation, and bone mineral density in children. J Clin Endocrinol Metab 83:3469-3475
27. Boot AM, de Muinck Keizer-Schrama S, Pols HA, Krenning EP, Drop SL 1998 Bone mineral density and body composition before and during treatment with gonadotropin-releasing hormone agonist in children with central precocious puberty and early puberty. J Clin Endocrinol Metab 83:370-373
28. Palmert MR, Mansfield MJ, Crowley Jr WF, Crigler Jr JF, Crawford JD, Boepple PA 1999 Is obesity an outcome of gonadotropin-releasing hormone agonist administration? Analysis of growth and body composition in 110 patients with central precocious puberty. J Clin Endocrinol Metab 84:4480-4488
29. Sävendahl L 2005 Hormonal regulation of growth plate cartilage. Horm Res 64:94-97
30. Weise M, De-Levy S, Barnes KM, Gafni RI, Abad V, Baron J 2001 Effects of estrogen on growth plate senescence and epiphyseal fusion. Proc Natl Acad Sci USA 98:6871-6876
31. Weise M, Flor A, Barnes KM, Cutler Jr GB, Baron J 2004 Determinants of growth during gonadotropin-releasing hormone analog therapy for precocious puberty. J Clin Endocrinol Metab 2004 89:103-107
32. Hall JM, McDonnell DP 1999 The estrogen receptor β-isoform (ERβ) of the human estrogen receptor modulates ERα transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology 140 5566-5578
33. Nilsson O, Chrysis D, Pajulo O, Boman A, Holst M, Rubinstein J, Martin Ritzén E, Sävendahl L 2003 Localization of estrogen receptors α and β and androgen receptor in the human growth plate at different pubertal stages. J Endocrinol 177:319-326
34. Ehrhardt AA, Meyer-Bahlburg HFL 1986 Idiopathic precocious puberty in girls: long-term effects on adolescent behavior. Acta Endocrinol Suppl (Cophenh) 279:247-253